, Oct. 22, 2012
/PRNewswire/ -- LABS, Inc., a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices, announced today the appointment of Ray W. Swanson
as its President and Chief Executive Officer.
Swanson has served in CEO and general management roles in both public and privately held growth companies focused on clinical diagnostics, medical technology and laboratory services including Centice Corporation, TriPath Imaging, Inc., Baxter International, Dade Behring and most recently Viracor-IBT Laboratories. Swanson has B.S. and M.S. degrees in zoology from Eastern Illinois University and an MBA from the University of Iowa.
"Ray has a remarkable track record of achieving cost-effective growth and transforming diagnostics and laboratory service businesses," said Kevin Cmunt, Chair of the LABS, Inc. Board of Directors. "We look forward to Ray helping LABS continue to provide the donation community the critical laboratory services it needs."
"I am thrilled to be able to join the LABS team at such an exciting time for the company," said Swanson. "The company's demonstrated commitment to quality, science and service excellence to the donation community is a great foundation upon which to build."
Swanson's primary responsibility will be to grow and enhance LABS' services to the donation community and he will be committed to upholding LABS' mission to provide quality laboratory services for outstanding patient outcomes. In addition, he will lead LABS' efforts to grow into new and exciting service areas that will bring further value to the donation community. LABS, Inc. employs nearly 200 people in Colorado and at its satellite laboratory in Philadelphia.
About LABS, Inc.
LABS, Inc. is a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices. LABS provides an intimate customer service experience, which results in personalized laboratory solutions for clients in any stage of the product development lifecycle: donor eligibility, R&D, processing and validation and final lot release.
LABS has an established and trusted record of personalized service, compliance and integrity. The Company serves a variety of industries that are focused on advancing and understanding biologic-based products.
The company is headquartered in Centennial, CO with a satellite facility in Philadelphia, PA. LABS receives sample shipments from across the globe and performs testing for 10 nations outside of the U.S.: Australia (TGA certified), Canada, Germany, Italy, Japan, Singapore, South Korea, Sweden, Switzerland and the United Kingdom. To learn more, visit www.labs-inc.org.
SOURCE LABS, Inc.